Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders ; volume:4 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-11 ; date:12.2024
Communications medicine ; 4, Heft 1 (5.1.2024), 1-11, 12.2024
- Creator
-
Lauffer, Marlen C.
van Roon-Mom, Willeke
Aartsma-Rus, Annemieke
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s43856-023-00419-1
- URN
-
urn:nbn:de:101:1-2024031821222922297110
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lauffer, Marlen C.
- van Roon-Mom, Willeke
- Aartsma-Rus, Annemieke
- SpringerLink (Online service)
Other Objects (12)
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Experimental thymectomy : Possibilities and limitations
Reparative Dentistry: Possibilities and Limitations
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Possibilities and limitations of intravital imaging
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Experimental thymectomy : Possibilities and limitations
Reparative Dentistry: Possibilities and Limitations
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Possibilities and limitations of intravital imaging
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)
Accessing Therapeutically‐Relevant Multifunctional Antisense Oligonucleotide Conjugates Using Native Chemical Ligation
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Pharmacological studies of antisense oligonucleotide microRNA inhibitors
Experimental thymectomy : Possibilities and limitations
Reparative Dentistry: Possibilities and Limitations
Profiled support vector machines for antisense oligonucleotide efficacy prediction
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity
Possibilities and limitations of intravital imaging
The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
CD47 antisense oligonucleotide treatment attenuates obesity and its-associated metabolic dysfunction
Development of antisense oligonucleotide combinatorial therapies for spinal muscular atrophy (SMA)